179 related articles for article (PubMed ID: 17698634)
1. Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).
Boruchov DM; Gururangan S; Driscoll MC; Bussel JB
Blood; 2007 Nov; 110(10):3526-31. PubMed ID: 17698634
[TBL] [Abstract][Full Text] [Related]
2. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
Gereige RS; Barrios NJ
P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
[TBL] [Abstract][Full Text] [Related]
3. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Schiavotto C; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children.
Ancona KG; Parker RI; Atlas MP; Prakash D
J Pediatr Hematol Oncol; 2002 Oct; 24(7):540-4. PubMed ID: 12368690
[TBL] [Abstract][Full Text] [Related]
6. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
Erduran E; Aslan Y; Gedik Y; Orhan F
Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
[TBL] [Abstract][Full Text] [Related]
7. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
8. Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.
Celik M; Bulbul A; Aydogan G; Tugcu D; Can E; Uslu S; Dursun M
J Thromb Thrombolysis; 2013 Feb; 35(2):228-33. PubMed ID: 22956408
[TBL] [Abstract][Full Text] [Related]
9. [Randomized comparison of intravenous immunoglobulin and methylprednisolone pulse therapy in children with newly diagnosed idiopathic thrombocytic purpura. The Danish ITP Study Group].
Rosthøj S; Nielsen SM; Pedersen FK
Ugeskr Laeger; 1998 Mar; 160(11):1640-4. PubMed ID: 9522658
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura. Danish I.T.P. Study Group.
Rosthøj S; Nielsen S; Pedersen FK
Acta Paediatr; 1996 Aug; 85(8):910-5. PubMed ID: 8863869
[TBL] [Abstract][Full Text] [Related]
12. Clinical features, treatment responses, and outcome of children with idiopathic thrombocytopenic purpura.
Demircioğlu F; Saygi M; Yilmaz S; Oren H; Irken G
Pediatr Hematol Oncol; 2009; 26(7):526-32. PubMed ID: 19863209
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute idiopathic thrombocytopenic purpura with high-dose methylprednisolone and immunoglobulin.
Barrios NJ; Humbert JR; McNeil J
Acta Haematol; 1993; 89(1):6-9. PubMed ID: 8480491
[TBL] [Abstract][Full Text] [Related]
15. Evans syndrome. Results of a pilot study utilizing a multiagent treatment protocol.
Scaradavou A; Bussel J
J Pediatr Hematol Oncol; 1995 Nov; 17(4):290-5. PubMed ID: 7583383
[TBL] [Abstract][Full Text] [Related]
16. Danazol therapy for chronic immune-mediated thrombocytopenic purpura in a patient with common variable immunodeficiency.
Saulsbury FT; Bringelsen KA
Am J Pediatr Hematol Oncol; 1991; 13(3):326-9. PubMed ID: 1793160
[TBL] [Abstract][Full Text] [Related]
17. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
Hedlund-Treutiger I; Henter JI; Elinder G
J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
[TBL] [Abstract][Full Text] [Related]
18. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy for refractory idiopathic thrombocytopenic purpura in adolescents.
Williams JA; Boxer LA
J Pediatr Hematol Oncol; 2003 Mar; 25(3):232-5. PubMed ID: 12621242
[TBL] [Abstract][Full Text] [Related]
20. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
